Eva Renee Barnett
Equibles does not estimate personal net worth.
About Eva Renee Barnett
Eva Renee Barnett was last confirmed as CFO at Immunovant, Inc. (IMVT) in a filing dated June 26, 2024. The proxy statement of Immunovant, Inc. reports total compensation of $3,227,452 for Eva Renee Barnett in fiscal 2026, including a base salary of $26,250. Disclosed compensation is on record for 5 fiscal years.
Affiliation history
-
Start not stated–2024-06-26
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2026 | Immunovant, Inc. (IMVT) | Former Chief Financial Officer | $26,250 | $3,227,452 |
| 2025 | Immunovant, Inc. (IMVT) | Former Chief Financial Officer | $481,000 | $3,970,734 |
| 2024 | Immunovant, Inc. (IMVT) | Former Chief Financial Officer | $465,000 | $3,338,969 |
| 2023 | Immunovant, Inc. (IMVT) | Former Chief Financial Officer | $435,000 | $2,070,095 |
| 2022 | Immunovant, Inc. (IMVT) | M.B.A. Chief Financial Officer | $198,485 | $4,427,051 |
Recent activity
No call appearances or filed executive changes recorded yet.